119 related articles for article (PubMed ID: 20798514)
1. RRM2 computational phosphoprotein network construction and analysis between no-tumor hepatitis/cirrhotic liver tissues and human hepatocellular carcinoma (HCC).
Wang L; Huang J; Jiang M
Cell Physiol Biochem; 2010; 26(3):303-10. PubMed ID: 20798514
[TBL] [Abstract][Full Text] [Related]
2. AFP computational secreted network construction and analysis between human hepatocellular carcinoma (HCC) and no-tumor hepatitis/cirrhotic liver tissues.
Wang L; Huang J; Jiang M; Zheng X
Tumour Biol; 2010 Oct; 31(5):417-25. PubMed ID: 20532728
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatics analysis of key genes and pathways for hepatocellular carcinoma transformed from cirrhosis.
He B; Yin J; Gong S; Gu J; Xiao J; Shi W; Ding W; He Y
Medicine (Baltimore); 2017 Jun; 96(25):e6938. PubMed ID: 28640074
[TBL] [Abstract][Full Text] [Related]
4. Survivin (BIRC5) cell cycle computational network in human no-tumor hepatitis/cirrhosis and hepatocellular carcinoma transformation.
Wang L; Huang J; Jiang M; Sun L
J Cell Biochem; 2011 May; 112(5):1286-94. PubMed ID: 21312234
[TBL] [Abstract][Full Text] [Related]
5. BRCA1-mediated inflammation and growth activated & inhibited transition mechanisms between no-tumor hepatitis/cirrhotic tissues and HCC.
Diao H; Wang L; Huang J; Jiang M; Zhou H; Li X; Chen Q; Jiang Z; Feng H
J Cell Biochem; 2014 Apr; 115(4):641-50. PubMed ID: 24151232
[TBL] [Abstract][Full Text] [Related]
6. Analysis of potential key genes in very early hepatocellular carcinoma.
Wu M; Liu Z; Li X; Zhang A; Lin D; Li N
World J Surg Oncol; 2019 May; 17(1):77. PubMed ID: 31043166
[TBL] [Abstract][Full Text] [Related]
7. Sorafenib Inhibits Ribonucleotide Reductase Regulatory Subunit M2 (RRM2) in Hepatocellular Carcinoma Cells.
Yang PM; Lin LS; Liu TP
Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31936661
[TBL] [Abstract][Full Text] [Related]
8. Cyclin-dependent kinase inhibitor 3 (CDKN3) novel cell cycle computational network between human non-malignancy associated hepatitis/cirrhosis and hepatocellular carcinoma (HCC) transformation.
Wang L; Sun L; Huang J; Jiang M
Cell Prolif; 2011 Jun; 44(3):291-9. PubMed ID: 21535270
[TBL] [Abstract][Full Text] [Related]
9. RASSF1A and DOK1 Promoter Methylation Levels in Hepatocellular Carcinoma, Cirrhotic and Non-Cirrhotic Liver, and Correlation with Liver Cancer in Brazilian Patients.
Araújo OC; Rosa AS; Fernandes A; Niel C; Villela-Nogueira CA; Pannain V; Araujo NM
PLoS One; 2016; 11(4):e0153796. PubMed ID: 27078152
[TBL] [Abstract][Full Text] [Related]
10. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma].
Lou C; Yang B; Gao YT; Wang YJ; Nie FH; Yuan Q; Zhang CL; Du Z
Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):831-6. PubMed ID: 19173828
[TBL] [Abstract][Full Text] [Related]
11. CREB5 computational regulation network construction and analysis between frontal cortex of HIV encephalitis (HIVE) and HIVE-control patients.
Wang L; Huang J; Jiang M
Cell Biochem Biophys; 2011 Jul; 60(3):199-207. PubMed ID: 21132541
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of hepatocellular carcinoma growth using immunoliposomes for co-delivery of adriamycin and ribonucleotide reductase M2 siRNA.
Gao J; Chen H; Yu Y; Song J; Song H; Su X; Li W; Tong X; Qian W; Wang H; Dai J; Guo Y
Biomaterials; 2013 Dec; 34(38):10084-98. PubMed ID: 24060417
[TBL] [Abstract][Full Text] [Related]
13. Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liver.
Masaki T; Tokuda M; Yoshida S; Nakai S; Morishita A; Uchida N; Funaki T; Kita Y; Funakoshi F; Nonomura T; Himoto T; Deguchi A; Kimura Y; Izuishi K; Wakabayashi H; Usuki H; Yoshiji H; Watanabe S; Kurokohchi K; Kuriyama S
Int J Oncol; 2005 Mar; 26(3):661-71. PubMed ID: 15703821
[TBL] [Abstract][Full Text] [Related]
14. High expression of ribonucleotide reductase subunit M2 correlates with poor prognosis of hepatocellular carcinoma.
Lee B; Ha SY; Song DH; Lee HW; Cho SY; Park CK
Gut Liver; 2014 Nov; 8(6):662-8. PubMed ID: 25368754
[TBL] [Abstract][Full Text] [Related]
15. A signature of six genes highlights defects on cell growth and specific metabolic pathways in murine and human hepatocellular carcinoma.
Schröder PC; Segura V; Riezu JI; Sangro B; Mato JM; Prieto J; Santamaría E; Corrales FJ
Funct Integr Genomics; 2011 Sep; 11(3):419-29. PubMed ID: 21562899
[TBL] [Abstract][Full Text] [Related]
16. Risk Factors for Hepatocellular Carcinoma in Cirrhotic Patients with Chronic Hepatitis B.
Zhang YQ; Peng LJ; Cao YR; Zeng ZP; Wu YJ; Shi H; Cheng SY; Wang JY; Friedman SL; Sninsky JJ; Guo JS
Genet Test Mol Biomarkers; 2016 Sep; 20(9):535-43. PubMed ID: 27391584
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometric DNA analysis of cirrhotic liver cells in patients with hepatocellular carcinoma can provide a new prognostic factor.
Ruà S; Comino A; Fruttero A; Torchio P; Bouzari H; Taraglio S; Torchio B; Capussotti L
Cancer; 1996 Sep; 78(6):1195-202. PubMed ID: 8826940
[TBL] [Abstract][Full Text] [Related]
18. Analysis of microarrays of miR-34a and its identification of prospective target gene signature in hepatocellular carcinoma.
Ren FH; Yang H; He RQ; Lu JN; Lin XG; Liang HW; Dang YW; Feng ZB; Chen G; Luo DZ
BMC Cancer; 2018 Jan; 18(1):12. PubMed ID: 29298665
[TBL] [Abstract][Full Text] [Related]
19. Selection of reference genes for RT-qPCR analysis in tumor tissues from male hepatocellular carcinoma patients with hepatitis B infection and cirrhosis.
Liu S; Zhu P; Zhang L; Ding S; Zheng S; Wang Y; Lu F
Cancer Biomark; 2013; 13(5):345-9. PubMed ID: 24440974
[TBL] [Abstract][Full Text] [Related]
20. MYBPC1 computational phosphoprotein network construction and analysis between frontal cortex of HIV encephalitis (HIVE) and HIVE-control patients.
Wang L; Huang J; Jiang M; Sun L
Cell Mol Neurobiol; 2011 Mar; 31(2):233-41. PubMed ID: 21061152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
